Status:
RECRUITING
Genetic Determinants of Exercise-Induced Muscle Damage (POLYGENDOMUS)
Lead Sponsor:
Lille University
Conditions:
Healthy
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the association between the evolution of plasma CPK levels and genetic polymorphisms, both before the muscle-damaging exercise and at three post-exercise tim...
Detailed Description
Elite-level sports expose athletes to training loads designed to induce muscle damage, aiming to achieve optimal physiological adaptations. However, the repetitive nature of such damage increases the ...
Eligibility Criteria
Inclusion
- Male or female
- Aged between 18 and 35
- Weighing more than 50 kg
- Member of a sports club affiliated to an Olympic federation
- Socially insured
- Willing to comply with all study procedures and duration of the study
Exclusion
- Medical history contraindicating sporting activities
- Current medical treatment
- Not a member of a sports club affiliated to an Olympic federation
- Administrative reasons: impossibility of receiving informed information, impossibility of participating in the entire study, absence of social security coverage, refusal to sign consent form.
Key Trial Info
Start Date :
March 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 19 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06740136
Start Date
March 13 2023
End Date
December 19 2025
Last Update
December 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eurasport
Loos, France, 59120